ImmuPharma (LON:IMM) Stock Crosses Below Two Hundred Day Moving Average of $5.94

ImmuPharma plc (LON:IMMGet Rating) shares passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 5.94 ($0.07) and traded as low as GBX 4.50 ($0.05). ImmuPharma shares last traded at GBX 4.82 ($0.06), with a volume of 204,449 shares changing hands.

ImmuPharma Price Performance

The company has a 50 day simple moving average of GBX 5.88 and a 200-day simple moving average of GBX 5.94. The stock has a market cap of £15.83 million and a price-to-earnings ratio of -1.46. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.02.

ImmuPharma Company Profile

(Get Rating)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Recommended Stories

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.